<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#Cover" roleURI="http://regenbiopharmainc.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#BalanceSheets" roleURI="http://regenbiopharmainc.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#BalanceSheetsParenthetical" roleURI="http://regenbiopharmainc.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#StatementsOfOperations" roleURI="http://regenbiopharmainc.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#StatementOfShareholdersDeficit" roleURI="http://regenbiopharmainc.com/role/StatementOfShareholdersDeficit" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#StatementOfCashFlows" roleURI="http://regenbiopharmainc.com/role/StatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#Organization" roleURI="http://regenbiopharmainc.com/role/Organization" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#AccountsReceivable" roleURI="http://regenbiopharmainc.com/role/AccountsReceivable" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#PrepaidExpenses" roleURI="http://regenbiopharmainc.com/role/PrepaidExpenses" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#AccruedExpenses" roleURI="http://regenbiopharmainc.com/role/AccruedExpenses" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#UnearnedIncome" roleURI="http://regenbiopharmainc.com/role/UnearnedIncome" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#NotesPayable" roleURI="http://regenbiopharmainc.com/role/NotesPayable" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#NotesPayableToRelatedParties" roleURI="http://regenbiopharmainc.com/role/NotesPayableToRelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ConvertibleNotesPayable" roleURI="http://regenbiopharmainc.com/role/ConvertibleNotesPayable" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#DerivativeLiability" roleURI="http://regenbiopharmainc.com/role/DerivativeLiability" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#StockholdersEquity" roleURI="http://regenbiopharmainc.com/role/StockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#RelatedPartyTransactions" roleURI="http://regenbiopharmainc.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#IncomeTaxes" roleURI="http://regenbiopharmainc.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#CommitmentsAndContingencies" roleURI="http://regenbiopharmainc.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#SubsequentEvents" roleURI="http://regenbiopharmainc.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#AccountsReceivableTables" roleURI="http://regenbiopharmainc.com/role/AccountsReceivableTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#PrepaidExpensesTables" roleURI="http://regenbiopharmainc.com/role/PrepaidExpensesTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#AccruedExpensesTables" roleURI="http://regenbiopharmainc.com/role/AccruedExpensesTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#NotesPayableTables" roleURI="http://regenbiopharmainc.com/role/NotesPayableTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#NotesPayableToRelatedPartiesTables" roleURI="http://regenbiopharmainc.com/role/NotesPayableToRelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ConvertibleNotesPayableTables" roleURI="http://regenbiopharmainc.com/role/ConvertibleNotesPayableTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#DerivativeLiabilityTables" roleURI="http://regenbiopharmainc.com/role/DerivativeLiabilityTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#IncomeTaxesTables" roleURI="http://regenbiopharmainc.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfFairValueHierarchyMeasuredAtRecurringBasisDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfFairValueHierarchyMeasuredAtRecurringBasisDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfDerivativeLiabilityOnConvertibleNotesUsingBlackScholesPricingModelDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfDerivativeLiabilityOnConvertibleNotesUsingBlackScholesPricingModelDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfAccountsReceivableDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfAccountsReceivableDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#AccountsReceivableDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/AccountsReceivableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfPrepaidExpensesDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfPrepaidExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfAccruedExpensesDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfAccruedExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#UnearnedIncomeDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/UnearnedIncomeDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfNotesPayableToNonRelatedPartyDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfNotesPayableToNonRelatedPartyDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#NotesPayableDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/NotesPayableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfNotesPayableToRelatedPartiesDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfNotesPayableToRelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#NotesPayableToRelatedPartiesDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/NotesPayableToRelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfConvertibleNotesDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfConvertibleNotesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfConvertibleNotesDetailsParenthetical" roleURI="http://regenbiopharmainc.com/role/ScheduleOfConvertibleNotesDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ConvertibleNotesPayableDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/ConvertibleNotesPayableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfDerivativeLiabilityDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfDerivativeLiabilityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#DerivativeLiabilityDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/DerivativeLiabilityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#StockholdersEquityDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/StockholdersEquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#RelatedPartyTransactionsDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/RelatedPartyTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#ScheduleOfDeferredTaxAssetsDetails" roleURI="http://regenbiopharmainc.com/role/ScheduleOfDeferredTaxAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#IncomeTaxesDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="rgbp-20260331.xsd#SubsequentEventsDetailsNarrative" roleURI="http://regenbiopharmainc.com/role/SubsequentEventsDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rgbp-20260331.xsd#RGBP_ConvertibleNotePayableCurrent" xlink:label="loc_RGBPConvertibleNotePayableCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_RGBPConvertibleNotePayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rgbp-20260331.xsd#RGBP_RentalExpense" xlink:label="loc_RGBPRentalExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_RGBPRentalExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaapOtherNoncashIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNoncashIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNoncashIncomeExpense" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNoncashIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNoncashIncomeExpense" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rgbp-20260331.xsd#RGBP_FinancingFees" xlink:label="loc_RGBPFinancingFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNoncashIncomeExpense" xlink:to="loc_RGBPFinancingFees" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNoncashIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/StatementOfShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Shareholders&apos; Deficit (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/StatementOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rgbp-20260331.xsd#RGBP_CommonStockIssuedForCompensation" xlink:label="loc_RGBPCommonStockIssuedForCompensation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGBPCommonStockIssuedForCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rgbp-20260331.xsd#RGBP_IncreaseDecreaseInCommonStockIssuedForExpenses" xlink:label="loc_RGBPIncreaseDecreaseInCommonStockIssuedForExpenses" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGBPIncreaseDecreaseInCommonStockIssuedForExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:label="loc_us-gaapIncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:label="loc_us-gaapIncreaseDecreaseInUnearnedPremiums" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInUnearnedPremiums" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromRepaymentsOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfSecuredDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfSecuredDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaapProceedsFromRepaymentsOfNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromOtherShortTermDebt" xlink:label="loc_us-gaapProceedsFromOtherShortTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromOtherShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rgbp-20260331.xsd#RGBP_BorrowingsFromNotesPayableToRelatedParties" xlink:label="loc_RGBPBorrowingsFromNotesPayableToRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RGBPBorrowingsFromNotesPayableToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/Organization" xlink:title="999007 - Disclosure - ORGANIZATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/AccountsReceivable" xlink:title="999009 - Disclosure - ACCOUNTS RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/PrepaidExpenses" xlink:title="999010 - Disclosure - PREPAID EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/AccruedExpenses" xlink:title="999011 - Disclosure - ACCRUED EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/UnearnedIncome" xlink:title="999012 - Disclosure - UNEARNED INCOME" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/NotesPayable" xlink:title="999013 - Disclosure - NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/NotesPayableToRelatedParties" xlink:title="999014 - Disclosure - NOTES PAYABLE TO RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ConvertibleNotesPayable" xlink:title="999015 - Disclosure - CONVERTIBLE NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/DerivativeLiability" xlink:title="999016 - Disclosure - DERIVATIVE LIABILITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/StockholdersEquity" xlink:title="999017 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/RelatedPartyTransactions" xlink:title="999018 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/IncomeTaxes" xlink:title="999019 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/CommitmentsAndContingencies" xlink:title="999020 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/SubsequentEvents" xlink:title="999021 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/AccountsReceivableTables" xlink:title="999024 - Disclosure - ACCOUNTS RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/PrepaidExpensesTables" xlink:title="999025 - Disclosure - PREPAID EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/AccruedExpensesTables" xlink:title="999026 - Disclosure - ACCRUED EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/NotesPayableTables" xlink:title="999027 - Disclosure - NOTES PAYABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/NotesPayableToRelatedPartiesTables" xlink:title="999028 - Disclosure - NOTES PAYABLE TO RELATED PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ConvertibleNotesPayableTables" xlink:title="999029 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/DerivativeLiabilityTables" xlink:title="999030 - Disclosure - DERIVATIVE LIABILITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/IncomeTaxesTables" xlink:title="999031 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfFairValueHierarchyMeasuredAtRecurringBasisDetails" xlink:title="999032 - Disclosure - SCHEDULE OF FAIR VALUE HIERARCHY MEASURED AT RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfDerivativeLiabilityOnConvertibleNotesUsingBlackScholesPricingModelDetails" xlink:title="999033 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY ON CONVERTIBLE NOTES USING BLACK SCHOLES PRICING MODEL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfAccountsReceivableDetails" xlink:title="999035 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/AccountsReceivableDetailsNarrative" xlink:title="999036 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfPrepaidExpensesDetails" xlink:title="999037 - Disclosure - SCHEDULE OF PREPAID EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfAccruedExpensesDetails" xlink:title="999038 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/UnearnedIncomeDetailsNarrative" xlink:title="999039 - Disclosure - UNEARNED INCOME (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfNotesPayableToNonRelatedPartyDetails" xlink:title="999040 - Disclosure - SCHEDULE OF NOTES PAYABLE TO NON RELATED PARTY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/NotesPayableDetailsNarrative" xlink:title="999041 - Disclosure - NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfNotesPayableToRelatedPartiesDetails" xlink:title="999042 - Disclosure - SCHEDULE OF NOTES PAYABLE TO RELATED PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/NotesPayableToRelatedPartiesDetailsNarrative" xlink:title="999043 - Disclosure - NOTES PAYABLE TO RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfConvertibleNotesDetails" xlink:title="999044 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfConvertibleNotesDetailsParenthetical" xlink:title="999045 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="999046 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfDerivativeLiabilityDetails" xlink:title="999047 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/DerivativeLiabilityDetailsNarrative" xlink:title="999048 - Disclosure - DERIVATIVE LIABILITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/StockholdersEquityDetailsNarrative" xlink:title="999049 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999050 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999051 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/IncomeTaxesDetailsNarrative" xlink:title="999052 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999053 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://regenbiopharmainc.com/role/SubsequentEventsDetailsNarrative" xlink:title="999054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
